Letter to the editor regarding: “A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population” clinica chimica acta 538 (2023) 211–215
- 1 March 2023
- journal article
- letter
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 542, 117271
- https://doi.org/10.1016/j.cca.2023.117271
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech populationClinica Chimica Acta; International Journal of Clinical Chemistry, 2022
- A first update on mapping the human genetic architecture of COVID-19Nature, 2022
- Iron and iron-related proteins in COVID-19Clinical and Experimental Medicine, 2022
- Genetic Polymorphisms in the Host and COVID-19 InfectionPublished by Springer Science and Business Media LLC ,2021
- Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic MalignancyJAMA, 2020
- Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK BiobankBMJ, 2019